Autoimmune hepatitis has been reported to recur after liver transplantation. The aim of our study was to evaluate the risk factors associated with recurrence of autoimmune hepatitis. Forty-six patients that underwent liver transplantation because of end-stage liver disease secondary to autoimmune he
✦ LIBER ✦
Recurrence of autoimmune hepatitis after liver transplantation
✍ Scribed by G Götz; R Neuhaus; W.O Bechstein; H Lobeck; T Berg; U Hopf; P Neuhaus
- Book ID
- 117237508
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 51 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Risk factors for recurrence of autoimmun
✍
Aldo J. Montano-Loza; Andrew L. Mason; Mang Ma; Ravin J. Bastiampillai; Vincent
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 196 KB
👁 1 views
Recurrence of autoimmune disease, primar
✍
Jean-Charles Duclos-Vallee; Mylène Sebagh
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 424 KB
👁 1 views
1. Recurrence of primary sclerosing cholangitis. a Five percent of liver transplants are performed because of end-stage liver disease secondary to primary sclerosing cholangitis. b Recurrent disease affects 10% to 27% of recipients. c Diagnostic criteria of recurrence include the following: A confir
Recurrence of primary biliary cirrhosis
✍
Prodromos Hytiroglou; Julio A. Gutierrez; Maria Freni; Joseph A. Odin; Carmen M.
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 686 KB
De novo autoimmune hepatitis subsequent
✍
Kazuki Takeishi; Ken Shirabe; Takeo Toshima; Toru Ikegami; Kazutoyo Morita; Taka
📂
Article
📅
2011
🏛
Springer
🌐
English
⚖ 287 KB
Recurrent autoimmune hepatitis after ort
✍
Alvaro González-Koch; Albert J. Czaja; Herschel A. Carpenter; Stuart K. Roberts;
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 416 KB
Recurrence of autoimmune hepatitis follo
✍
Devlin, John ;Donaldson, Peter ;Portmann, Bernard ;Heaton, Nigel ;Tan, Kai-Chah
📂
Article
📅
1995
🏛
Wiley (John Wiley & Sons)
🌐
English
⚖ 771 KB
ards that may ensue with low or, indeed, as recently proposed, withdrawal of pharmacological immunosuppression in this particular group of recipients are also emphasised.